FPHAX vs. FBTTX
Compare and contrast key facts about Fidelity Select Pharmaceuticals Portfolio (FPHAX) and Fidelity Advisor Biotechnology Fund Class M (FBTTX).
FPHAX is managed by Fidelity. It was launched on Jun 17, 2001. FBTTX is managed by Fidelity. It was launched on Dec 27, 2000.
Performance
FPHAX vs. FBTTX - Performance Comparison
Loading graphics...
FPHAX vs. FBTTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FPHAX Fidelity Select Pharmaceuticals Portfolio | 0.39% | 30.41% | 9.39% | 12.54% | 0.94% | 11.79% | 11.16% | 31.73% | 5.41% | 10.70% |
FBTTX Fidelity Advisor Biotechnology Fund Class M | 2.18% | 39.21% | 5.08% | 10.43% | -8.22% | -3.35% | 31.82% | 25.39% | -4.19% | 25.37% |
Returns By Period
In the year-to-date period, FPHAX achieves a 0.39% return, which is significantly lower than FBTTX's 2.18% return. Both investments have delivered pretty close results over the past 10 years, with FPHAX having a 11.27% annualized return and FBTTX not far ahead at 11.54%.
FPHAX
- 1D
- 3.02%
- 1M
- -5.31%
- YTD
- 0.39%
- 6M
- 13.18%
- 1Y
- 34.09%
- 3Y*
- 17.36%
- 5Y*
- 12.54%
- 10Y*
- 11.27%
FBTTX
- 1D
- 5.09%
- 1M
- -0.77%
- YTD
- 2.18%
- 6M
- 15.39%
- 1Y
- 55.03%
- 3Y*
- 20.14%
- 5Y*
- 8.63%
- 10Y*
- 11.54%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FPHAX vs. FBTTX - Expense Ratio Comparison
FPHAX has a 0.75% expense ratio, which is lower than FBTTX's 1.28% expense ratio.
Return for Risk
FPHAX vs. FBTTX — Risk / Return Rank
FPHAX
FBTTX
FPHAX vs. FBTTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Pharmaceuticals Portfolio (FPHAX) and Fidelity Advisor Biotechnology Fund Class M (FBTTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FPHAX | FBTTX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.33 | 1.92 | -0.60 |
Sortino ratioReturn per unit of downside risk | 1.84 | 2.52 | -0.68 |
Omega ratioGain probability vs. loss probability | 1.24 | 1.32 | -0.09 |
Calmar ratioReturn relative to maximum drawdown | 2.50 | 3.13 | -0.64 |
Martin ratioReturn relative to average drawdown | 7.03 | 12.48 | -5.45 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FPHAX | FBTTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.33 | 1.92 | -0.60 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.71 | 0.37 | +0.34 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.64 | 0.47 | +0.16 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.53 | 0.30 | +0.23 |
Correlation
The correlation between FPHAX and FBTTX is 0.75, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
FPHAX vs. FBTTX - Dividend Comparison
FPHAX's dividend yield for the trailing twelve months is around 5.66%, more than FBTTX's 1.50% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FPHAX Fidelity Select Pharmaceuticals Portfolio | 5.66% | 5.68% | 1.90% | 8.08% | 5.18% | 11.09% | 8.85% | 8.33% | 1.65% | 1.62% | 1.07% | 12.63% |
FBTTX Fidelity Advisor Biotechnology Fund Class M | 1.50% | 1.53% | 6.41% | 0.93% | 0.00% | 21.60% | 8.79% | 7.10% | 2.64% | 0.00% | 0.00% | 5.42% |
Drawdowns
FPHAX vs. FBTTX - Drawdown Comparison
The maximum FPHAX drawdown since its inception was -38.26%, smaller than the maximum FBTTX drawdown of -63.75%. Use the drawdown chart below to compare losses from any high point for FPHAX and FBTTX.
Loading graphics...
Drawdown Indicators
| FPHAX | FBTTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.26% | -63.75% | +25.49% |
Max Drawdown (1Y)Largest decline over 1 year | -11.00% | -13.58% | +2.58% |
Max Drawdown (5Y)Largest decline over 5 years | -28.82% | -36.64% | +7.82% |
Max Drawdown (10Y)Largest decline over 10 years | -28.82% | -39.04% | +10.22% |
Current DrawdownCurrent decline from peak | -7.10% | -2.61% | -4.49% |
Average DrawdownAverage peak-to-trough decline | -9.21% | -21.95% | +12.74% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.30% | 3.72% | +0.58% |
Volatility
FPHAX vs. FBTTX - Volatility Comparison
The current volatility for Fidelity Select Pharmaceuticals Portfolio (FPHAX) is 6.89%, while Fidelity Advisor Biotechnology Fund Class M (FBTTX) has a volatility of 9.37%. This indicates that FPHAX experiences smaller price fluctuations and is considered to be less risky than FBTTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FPHAX | FBTTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.89% | 9.37% | -2.48% |
Volatility (6M)Calculated over the trailing 6-month period | 14.30% | 17.02% | -2.72% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.52% | 25.99% | -2.47% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.74% | 23.31% | -5.57% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.81% | 24.58% | -6.77% |